NCT00844129View on ClinicalTrials.gov

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Neurofibromatosis Type 1
Trial Locations (1)

84132

University Health Care, 50 North Medical Drive, Salt Lake City

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Utah

OTHER

NCT00844129 - Spinal Abnormalities in Neurofibromatosis Type 1 (NF1) | Biotech Hunter | Biotech Hunter